Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 13 studies | 21% ± 5% | |
brain | 12 studies | 26% ± 10% | |
eye | 8 studies | 30% ± 11% | |
lung | 7 studies | 23% ± 7% | |
lymph node | 4 studies | 20% ± 4% | |
pancreas | 3 studies | 38% ± 12% | |
bone marrow | 3 studies | 15% ± 0% | |
intestine | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 22585.84 | 2642 / 2642 | 100% | 245.38 | 705 / 705 |
esophagus | 100% | 8952.19 | 1445 / 1445 | 100% | 68.59 | 183 / 183 |
liver | 100% | 8941.04 | 226 / 226 | 100% | 92.76 | 406 / 406 |
ovary | 100% | 10585.76 | 180 / 180 | 100% | 94.80 | 430 / 430 |
uterus | 100% | 9461.46 | 170 / 170 | 100% | 81.26 | 458 / 459 |
thymus | 100% | 9191.70 | 652 / 653 | 100% | 132.59 | 604 / 605 |
prostate | 100% | 10760.76 | 245 / 245 | 100% | 121.11 | 500 / 502 |
adrenal gland | 100% | 19883.72 | 258 / 258 | 100% | 152.67 | 229 / 230 |
kidney | 100% | 10368.58 | 89 / 89 | 99% | 104.09 | 896 / 901 |
pancreas | 99% | 7078.55 | 325 / 328 | 100% | 84.60 | 178 / 178 |
skin | 99% | 9578.55 | 1792 / 1809 | 100% | 137.12 | 472 / 472 |
intestine | 100% | 9074.99 | 966 / 966 | 99% | 65.29 | 522 / 527 |
breast | 100% | 11455.11 | 459 / 459 | 99% | 100.92 | 1102 / 1118 |
lung | 100% | 12013.04 | 577 / 578 | 99% | 82.80 | 1139 / 1155 |
stomach | 100% | 9021.74 | 359 / 359 | 98% | 63.69 | 281 / 286 |
bladder | 100% | 9336.43 | 21 / 21 | 98% | 76.66 | 492 / 504 |
adipose | 100% | 10559.80 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 143.79 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 84.53 | 29 / 29 |
peripheral blood | 100% | 17634.60 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 11276.88 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 73.93 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 60.79 | 1 / 1 |
blood vessel | 100% | 10573.89 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 13138.03 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 9076.28 | 835 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043627 | Biological process | response to estrogen |
GO_0071169 | Biological process | establishment of protein localization to chromatin |
GO_0050847 | Biological process | progesterone receptor signaling pathway |
GO_0071391 | Biological process | cellular response to estrogen stimulus |
GO_0033148 | Biological process | positive regulation of intracellular estrogen receptor signaling pathway |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0032570 | Biological process | response to progesterone |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | WBP2 |
Protein name | WW domain binding protein 2 WW domain binding protein 2 (cDNA FLJ59459, highly similar to WW domain-binding protein 2) WW domain-binding protein 2 (WBP-2) Alternative protein WBP2 |
Synonyms | |
Description | FUNCTION: Acts as a transcriptional coactivator of estrogen and progesterone receptors (ESR1 and PGR) upon hormone activation . In presence of estrogen, binds to ESR1-responsive promoters . Required for YAP1 coactivation function on PGR activity . Synergizes with WBP2 in enhancing PGR activity . Modulates expression of post-synaptic scaffolding proteins via regulation of ESR1, ESR2 and PGR (By similarity). . |
Accessions | ENST00000254806.8 [Q969T9-1] K7EIN1 ENST00000585462.5 ENST00000591831.5 ENST00000588373.5 ENST00000586257.5 K7ESN4 ENST00000590221.5 K7EJ75 ENST00000433525.6 [Q969T9-2] K7EIK1 ENST00000626827.2 ENST00000587374.5 Q969T9 A6NG10 ENST00000593002.1 ENST00000589642.5 K7ENL2 L0R5E7 K7EMC9 K7EIJ0 ENST00000591399.5 [Q969T9-1] |